Tolbutamide and Inability to speak - from FDA reports
Inability to speak is reported only by a few people who take Tolbutamide. We study 615 people who have side effects while taking Tolbutamide from FDA. Among them, 5 have Inability to speak. Find out below who they are, when they have Inability to speak and more.
How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.
Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).
615 people reported to have side effects when taking Tolbutamide.
Among them, 5 people (0.81%) have Inability to speak
Number of reports submitted per year:
Gender of people who have Inability to speak when taking Tolbutamide *:
- female: 20 %
- male: 80 %
Age of people who have Inability to speak when taking Tolbutamide *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
Top conditions involved for these people *:
- Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 20.00%
- Hypoaesthesia (reduced sense of touch or sensation): 1 person, 20.00%
- High Blood Pressure: 1 person, 20.00%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 20.00%
Top co-used drugs for these people *:
- Symbicort: 1 person, 20.00%
- Sunitinib Malate: 1 person, 20.00%
- Simvastatin: 1 person, 20.00%
- Omeprazole: 1 person, 20.00%
- Norvasc: 1 person, 20.00%
Top other side effects for these people *:
- Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 2 people, 40.00%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 20.00%
- Stress And Anxiety: 1 person, 20.00%
- Blood Pressure Systolic Increased: 1 person, 20.00%
- Cerebral Haemorrhage (bleeding within the brain): 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
FDA reports used in this study
- Want to find out more about the FDA reports used in the study? You can request them from FDA.
Do you have Inability to speak while taking Tolbutamide?
- Check whether a drug or a condition causes Inability to speak
- Subscribe to monitor Inability to speak in Tolbutamide
You are not alone:
Tolbutamide has active ingredients of tolbutamide. It is often used in diabetes. (latest outcomes from Tolbutamide 618 users)
Inability to speak
Inability to speak has been reported by people with multiple sclerosis, high blood pressure, depression, pain, rheumatoid arthritis (latest reports from 53,364 Inability to speak patients).
Drugs that are associated with Inability to speakInability to speak (2,625 drugs)
Could your condition cause Inability to speakInability to speak (2,676 conditions)
Tolbutamide side effects
- Tolbutamide side effects (615 reports)
Browse all side effects of Tolbutamidea b c d e f g h i j k l m n o p q r s t u v w x y z
What would happen?
Recent general studies
- Will you have Intrauterine Adhesion with Xeloda? - now
- Will you have Pelvic Adhesion with Xeloda? - now
- Will you have Vision Impairment with Flonase? - a second ago
- Will you have Ra with Oedema? - 3 seconds ago
- Will you have Arthritis - Rheumatoid with Oedema? - 3 seconds ago
Recent personal studies
- A study for a 61 year old woman who takes Mobic, Meloxicam - 8 minutes ago
- A study for a 61 year old woman who takes Melatonin, Mobic - 13 minutes ago
- A study for a 16 year old boy who takes Seroquel - 2 hours ago
- A study for a 63 year old man who takes Cialis - 2 hours ago
- A study for a 44 year old woman who takes Klonopin, Flexeril, Fish Oil, Ginger, Magnesium Citrate, Fioricet, Probiotics, Trokendi Xr, Minipress, Metformin, L-glutamine, Turmeric - 2 hours ago
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.